Nuvation Bio, Inc. (NUVB)

4.475 +0.02 (+0.56%) USD  |  NYSE  |  Oct 19, 16:00
4.475 0.00 (0.00%) After-Hours: 17:21
More

Nuvation Bio Cash from Operations (Annual) : -173.43M for Dec. 31, 2025

Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2025 -173.43M
December 31, 2024 -130.41M
December 31, 2023 -68.00M
Date Value
December 31, 2022 -96.11M
December 31, 2021 -68.19M
December 31, 2020 -36.53M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Bristol Myers Squibb Co. 14.16B
Johnson & Johnson 24.53B
Pfizer Inc. 11.70B
Eli Lilly & Co. 16.81B
Merck & Co., Inc. 16.47B